Cases & Deals

  • Home
  • Practices
  • Micreos teams up with L'Oréal for skin care products containing endolysins

Share

Micreos teams up with L'Oréal for skin care products containing endolysins

October 2020

Client(s) Micreos Human Health B.V.

Jones Day represented Micreos Human Health B.V. in its license out to L'Oréal of endolysin technology that targets harmful skin bacteria while preserving useful bacteria for L'Oréal's use worldwide in skin care products for cosmetic applications. Micreos sells such products under the GLADSKIN brand.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.